Published in J Am Soc Nephrol on February 23, 2012
Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling. PLoS One (2013) 1.26
Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair. Immunity (2015) 1.26
TGF-β: the master regulator of fibrosis. Nat Rev Nephrol (2016) 1.19
Role of epidermal growth factor receptor in acute and chronic kidney injury. Kidney Int (2013) 1.14
Epidermal growth factor receptor inhibition slows progression of diabetic nephropathy in association with a decrease in endoplasmic reticulum stress and an increase in autophagy. Diabetes (2014) 1.06
Molecular targets for treatment of kidney fibrosis. J Mol Med (Berl) (2012) 1.06
The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis. J Gastroenterol (2013) 1.04
Sustained activation of EGFR triggers renal fibrogenesis after acute kidney injury. Am J Pathol (2013) 1.01
EGF receptor deletion in podocytes attenuates diabetic nephropathy. J Am Soc Nephrol (2014) 0.93
Blocking sirtuin 1 and 2 inhibits renal interstitial fibroblast activation and attenuates renal interstitial fibrosis in obstructive nephropathy. J Pharmacol Exp Ther (2014) 0.90
Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis. Kidney Int (2016) 0.90
Epidermal growth factors in the kidney and relationship to hypertension. Am J Physiol Renal Physiol (2013) 0.88
A bioinformatics approach identifies signal transducer and activator of transcription-3 and checkpoint kinase 1 as upstream regulators of kidney injury molecule-1 after kidney injury. J Am Soc Nephrol (2013) 0.85
EGFR activity is required for renal tubular cell dedifferentiation and proliferation in a murine model of folic acid-induced acute kidney injury. Am J Physiol Renal Physiol (2012) 0.85
P300-dependent STAT3 acetylation is necessary for angiotensin II-induced pro-fibrotic responses in renal tubular epithelial cells. Acta Pharmacol Sin (2014) 0.83
Treatment of chronic kidney diseases with histone deacetylase inhibitors. Front Physiol (2015) 0.83
EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy. J Am Soc Nephrol (2015) 0.82
Plumbagin Ameliorates CCl 4 -Induced Hepatic Fibrosis in Rats via the Epidermal Growth Factor Receptor Signaling Pathway. Evid Based Complement Alternat Med (2015) 0.81
Hypoxia: The Force that Drives Chronic Kidney Disease. Clin Med Res (2016) 0.80
Necrotic renal epithelial cell inhibits renal interstitial fibroblast activation: role of protein tyrosine phosphatase 1B. Am J Physiol Renal Physiol (2013) 0.80
Simultaneous deletion of Bax and Bak is required to prevent apoptosis and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol (2015) 0.79
Inhibition of STAT3 acetylation is associated with angiotesin renal fibrosis in the obstructed kidney. Acta Pharmacol Sin (2014) 0.79
Activation of Sirtuin-1 Promotes Renal Fibroblast Activation and Aggravates Renal Fibrogenesis. J Pharmacol Exp Ther (2015) 0.79
ADAM17 substrate release in proximal tubule drives kidney fibrosis. JCI Insight (2016) 0.79
Combined Effects of PPAR γ Agonists and Epidermal Growth Factor Receptor Inhibitors in Human Proximal Tubule Cells. PPAR Res (2013) 0.77
PDGF-D expression is down-regulated by TGFβ in fibroblasts. PLoS One (2014) 0.77
Anti-fibrotic effect of natural toxin bee venom on animal model of unilateral ureteral obstruction. Toxins (Basel) (2015) 0.77
EGFR signaling in renal fibrosis. Kidney Int Suppl (2011) (2014) 0.77
Renal cortical hexokinase and pentose phosphate pathway activation through the EGFR/Akt signaling pathway in endotoxin-induced acute kidney injury. Am J Physiol Renal Physiol (2014) 0.76
Inhibition of EGF Receptor Blocks the Development and Progression of Peritoneal Fibrosis. J Am Soc Nephrol (2015) 0.76
Progression of chronic kidney disease: too much cellular talk causes damage. Kidney Int (2016) 0.75
Structural basis of selectivity and neutralizing activity of a TGFα/epiregulin specific antibody. Protein Sci (2016) 0.75
Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis. Oncotarget (2016) 0.75
Absence of miR-146a in podocytes increases risk of diabetic glomerulopathy via upregulation of erbb4 and notch-1. J Biol Chem (2016) 0.75
Selective activation of epidermal growth factor receptor in renal proximal tubule induces tubulointerstitial fibrosis. FASEB J (2017) 0.75
Nephronophthisis: should we target cysts or fibrosis? Pediatr Nephrol (2015) 0.75
Cellular and molecular mechanisms of fibrosis. J Pathol (2008) 14.01
Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol (2009) 7.34
Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int (2006) 4.87
Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med (2010) 4.76
Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int (2009) 4.02
The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev (1994) 3.42
Molecular basis of renal fibrosis. Pediatr Nephrol (2000) 2.71
TGF-beta in renal injury and disease. Semin Nephrol (2007) 2.65
Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach. Nat Med (2005) 2.61
EGFR signal transactivation in cancer cells. Biochem Soc Trans (2003) 2.42
A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy. Kidney Int (2010) 2.32
Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J Clin Invest (2010) 2.23
The pathological role of Bax in cisplatin nephrotoxicity. Kidney Int (2007) 1.82
TGF-beta, Smad3 and the process of progressive fibrosis. Biochem Soc Trans (2007) 1.77
Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat Rev Nephrol (2009) 1.76
Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury. J Clin Invest (2000) 1.68
Nestin expression in the kidney with an obstructed ureter. Kidney Int (2007) 1.66
The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology. Exp Cell Res (2008) 1.53
Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol (2009) 1.53
TGF-beta signal transduction in chronic kidney disease. Front Biosci (Landmark Ed) (2009) 1.41
The renal cortical fibroblast in renal tubulointerstitial fibrosis. Int J Biochem Cell Biol (2005) 1.27
Proximal tubular cells promote fibrogenesis by TGF-beta1-mediated induction of peritubular myofibroblasts. Kidney Int (2002) 1.24
Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy. Kidney Int (2009) 1.15
TGF-alpha mediates genetic susceptibility to chronic kidney disease. J Am Soc Nephrol (2010) 1.08
PKC-beta1 mediates glucose-induced Akt activation and TGF-beta1 upregulation in mesangial cells. J Am Soc Nephrol (2009) 1.07
Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells. Kidney Int (2001) 1.05
Ligand release-independent transactivation of epidermal growth factor receptor by transforming growth factor-beta involves multiple signaling pathways. Oncogene (2007) 1.01
Epidermal growth factor receptor inhibitors in cancer treatment. Future Oncol (2005) 0.98
Endothelin-1 activates mesangial cell ERK1/2 via EGF-receptor transactivation and caveolin-1 interaction. Am J Physiol Renal Physiol (2002) 0.97
Epidermal growth factor receptor trans-activation mediates the tonic and fibrogenic effects of endothelin in the aortic wall of transgenic mice. FASEB J (2002) 0.93
Endothelin-1 induces p66Shc activation through EGF receptor transactivation: Role of beta(1)Pix/Galpha(i3) interaction. Cell Signal (2009) 0.89
The interdependence of EGF-R and SGK-1 in fibronectin expression in primary kidney cortical fibroblast cells. Int J Biochem Cell Biol (2007) 0.86
Cell-type-specific activation of mitogen-activated protein kinases in PAN-induced progressive renal disease in rats. Biochem Biophys Res Commun (2004) 0.85
Prevalence of chronic kidney disease: a systematic review and meta-analysis. Clin Nephrol (2009) 0.84
Small-molecule epidermal growth factor receptor tyrosine kinase inhibitors. Oncologist (2003) 0.84
Transforming growth factorbeta(1) transactivates EGFR via an H(2)O(2)-dependent mechanism in squamous carcinoma cell line. Cancer Lett (2009) 0.84
Transforming growth factor-beta production during the development of renal fibrosis in rats with subtotal renal ablation. Int J Exp Pathol (1996) 0.82
Epidermal growth factor receptor expression in human renal allograft biopsies: an immunohistochemical study. Transpl Immunol (2004) 0.82
N-cadherin is depleted from proximal tubules in experimental and human acute kidney injury. Histochem Cell Biol (2010) 0.81
Advanced glycation end-products activate extracellular signal-regulated kinase via the oxidative stress-EGF receptor pathway in renal fibroblasts. J Cell Biochem (2010) 0.81
Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med (2013) 8.91
Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol (2008) 3.65
A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy. Kidney Int (2010) 2.32
Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. Hepatology (2006) 1.64
Candesartan suppresses chronic renal inflammation by a novel antioxidant action independent of AT1R blockade. Kidney Int (2008) 1.62
P2X7 receptors mediate deleterious renal epithelial-fibroblast cross talk. Am J Physiol Renal Physiol (2010) 1.57
Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol (2009) 1.53
Histone deacetylase: a potential therapeutic target for fibrotic disorders. J Pharmacol Exp Ther (2010) 1.51
Hepatocyte growth factor suppresses proinflammatory NFkappaB activation through GSK3beta inactivation in renal tubular epithelial cells. J Biol Chem (2008) 1.42
The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. J Vasc Interv Radiol (2005) 1.28
Delayed administration of a single dose of lithium promotes recovery from AKI. J Am Soc Nephrol (2014) 1.28
Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling. PLoS One (2013) 1.26
Long-term, high-dosage candesartan suppresses inflammation and injury in chronic kidney disease: nonhemodynamic renal protection. J Am Soc Nephrol (2007) 1.17
Histone deacetylases as targets for treatment of multiple diseases. Clin Sci (Lond) (2013) 1.16
Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES. J Am Soc Nephrol (2004) 1.15
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for early acute kidney injury. Crit Care Clin (2011) 1.15
Role of epidermal growth factor receptor in acute and chronic kidney injury. Kidney Int (2013) 1.14
Anti-inflammatory effect of hepatocyte growth factor in chronic kidney disease: targeting the inflamed vascular endothelium. J Am Soc Nephrol (2006) 1.14
Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis. J Pharmacol Exp Ther (2012) 1.12
HSP72 attenuates renal tubular cell apoptosis and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol (2008) 1.10
Suramin inhibits renal fibrosis in chronic kidney disease. J Am Soc Nephrol (2011) 1.07
Variants of the natural resistance-associated macrophage protein 1 gene (NRAMP1) are associated with severe forms of pulmonary tuberculosis. Clin Infect Dis (2005) 1.06
T cells and in situ cryoglobulin deposition in the pathogenesis of lupus nephritis. Clin Immunol (2008) 1.04
Activation of PI3K-Akt-GSK3beta pathway mediates hepatocyte growth factor inhibition of RANTES expression in renal tubular epithelial cells. Biochem Biophys Res Commun (2005) 1.02
HDAC inhibition promotes cardiogenesis and the survival of embryonic stem cells through proteasome-dependent pathway. J Cell Biochem (2011) 1.02
Acetylation modulates prolactin receptor dimerization. Proc Natl Acad Sci U S A (2010) 1.01
Sustained activation of EGFR triggers renal fibrogenesis after acute kidney injury. Am J Pathol (2013) 1.01
Evaluation of a recombinant multiepitope peptide for serodiagnosis of Toxoplasma gondii infection. Clin Vaccine Immunol (2012) 1.00
Hepatocyte growth factor modulates matrix metalloproteinases and plasminogen activator/plasmin proteolytic pathways in progressive renal interstitial fibrosis. J Am Soc Nephrol (2003) 0.99
HSP72 inhibits Smad3 activation and nuclear translocation in renal epithelial-to-mesenchymal transition. J Am Soc Nephrol (2010) 0.99
Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials. Perit Dial Int (2010) 0.99
Inhibition of glycogen synthase kinase-3β prevents NSAID-induced acute kidney injury. Kidney Int (2012) 0.98
Histone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins. J Cell Biochem (2011) 0.98
Suicide gene therapy for hepatocellular carcinoma cells by survivin promoter-driven expression of the herpes simplex virus thymidine kinase gene. Oncol Rep (2013) 0.97
Peroxisome proliferator-activated receptor agonist treatment of alcohol-induced hepatic insulin resistance. Hepatol Res (2011) 0.93
Heat shock protein 72 enhances autophagy as a protective mechanism in lipopolysaccharide-induced peritonitis in rats. Am J Pathol (2011) 0.92
Nocturnal versus conventional haemodialysis: some current issues. Nephrol Dial Transplant (2009) 0.91
Redox-sensitive glycogen synthase kinase 3β-directed control of mitochondrial permeability transition: rheostatic regulation of acute kidney injury. Free Radic Biol Med (2013) 0.89
An inducible mouse model for PAX2-dependent glomerular disease: insights into a complex pathogenesis. Curr Biol (2006) 0.89
ERK pathway mediates P2X7 expression and cell death in renal interstitial fibroblasts exposed to necrotic renal epithelial cells. Am J Physiol Renal Physiol (2011) 0.88
Hepatocyte growth factor ameliorates progression of interstitial fibrosis in rats with established renal injury. Kidney Int (2004) 0.88
Adrenocorticotropic hormone ameliorates acute kidney injury by steroidogenic-dependent and -independent mechanisms. Kidney Int (2013) 0.88
Regulation of dedifferentiation and redifferentiation in renal proximal tubular cells by the epidermal growth factor receptor. J Pharmacol Exp Ther (2008) 0.88
Transglutaminase-1 protects renal epithelial cells from hydrogen peroxide-induced apoptosis through activation of STAT3 and AKT signaling pathways. Am J Physiol Renal Physiol (2009) 0.87
HDAC inhibition elicits myocardial protective effect through modulation of MKK3/Akt-1. PLoS One (2013) 0.87
Conditional ablation of glycogen synthase kinase 3β in postnatal mouse kidney. Lab Invest (2010) 0.87
Src regulates cell cycle protein expression and renal epithelial cell proliferation via PI3K/Akt signaling-dependent and -independent mechanisms. Am J Physiol Renal Physiol (2008) 0.86
Transglutaminase-1 regulates renal epithelial cell proliferation through activation of Stat-3. J Biol Chem (2008) 0.85
Direct fibrogenic effects of aldosterone on normotensive kidney: an effect modified by 11β-HSD activity. Am J Physiol Renal Physiol (2010) 0.85
Suramin alleviates glomerular injury and inflammation in the remnant kidney. PLoS One (2012) 0.85
EGFR activity is required for renal tubular cell dedifferentiation and proliferation in a murine model of folic acid-induced acute kidney injury. Am J Physiol Renal Physiol (2012) 0.85
Inflammation and oxidative stress in obesity-related glomerulopathy. Int J Nephrol (2012) 0.85
Tissue protective and anti-fibrotic actions of suramin: new uses of an old drug. Curr Clin Pharmacol (2011) 0.85
Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy. J Pharmacol Exp Ther (2011) 0.84